Analyst consensus rating
BioRestorative Therapies Analyst Rating: none
Direct answer
BioRestorative Therapies's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.00.
Forecast evidence checked September 3, 2026.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.14
- Average price target
- $8.00
- High price target
- $15.00
- Low price target
- $1.00
- Low target gap
- +595.9%
- Target upside
- +5,467.2%
- High target gap
- +10,338.4%
- Target range width
- 9,742.5%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- September 3, 2026
- Valid through
- September 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioRestorative Therapies?
BioRestorative Therapies has a verified none consensus. The same dataset has an average price target of $8.00.
How far are BioRestorative Therapies's low and high targets from the recorded price?
The low target implies +595.9%, while the high target implies +10,338.4%.
How many analysts are included in BioRestorative Therapies's consensus?
The verified consensus includes 2 analysts.
How is BioRestorative Therapies's target upside or downside calculated?
The average target of $8.00 is divided by the recorded price of $0.14, then one is subtracted to produce +5,467.2%. This does not guarantee a future return.
When was BioRestorative Therapies's analyst forecast verified?
The data was verified on 2026-09-03. The dataset is valid through 2026-09-10.